Metropolitan Life Insurance CO Karuna Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jun 14, 2023	BUY	$191.53 - $236.82 $357,586 - $442,142	1,867 New	1,867 $367 Million
Q4 2022 Mar 30, 2023	BUY	$191.53 - $236.82 $18,386 - $22,734	96 Added 5.42%	1,867 $366,000
Q4 2022 Feb 15, 2023	BUY	$191.53 - $236.82 $18,386 - $22,734	96 Added 5.42%	1,867 $366,000
Q3 2022 Jun 14, 2023	BUY	$123.79 - $277.42 $219,232 - $491,310	1,771 New	1,771 $398 Million
Q3 2022 Mar 30, 2023	BUY	$123.79 - $277.42 $22,901 - $51,322	185 Added 11.66%	1,771 $398,000
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $22,901 - $51,322	185 Added 11.66%	1,771 $398,000
Q2 2022 Jun 20, 2023	BUY	$93.97 - $143.33 $149,036 - $227,321	1,586 New	1,586 $200,000
Q2 2022 Mar 30, 2023	BUY	$93.97 - $143.33 $17,102 - $26,086	182 Added 12.96%	1,586 $200,000
Q2 2022 Aug 11, 2022	BUY	$93.97 - $143.33 $17,102 - $26,086	182 Added 12.96%	1,586 $201,000
Q1 2022 Jun 20, 2023	BUY	$98.9 - $132.37 $138,855 - $185,847	1,404 New	1,404 $178,000
Q1 2022 Mar 30, 2023	SELL	$98.9 - $132.37 $429,127 - $574,353	-4,339 Reduced 75.55%	1,404 $178,000
Q1 2022 May 12, 2022	SELL	$98.9 - $132.37 $429,127 - $574,353	-4,339 Reduced 75.55%	1,404 $178,000
Q4 2021 Jun 21, 2023	BUY	$110.64 - $159.4 $635,405 - $915,434	5,743 New	5,743 $752,000
Q4 2021 Mar 30, 2023	SELL	$110.64 - $159.4 $42,485 - $61,209	-384 Reduced 6.27%	5,743 $752,000
Q4 2021 Feb 15, 2022	SELL	$110.64 - $159.4 $42,485 - $61,209	-384 Reduced 6.27%	5,743 $752,000
Q3 2021 Jun 21, 2023	BUY	$101.2 - $125.87 $620,052 - $771,205	6,127 New	6,127 $749,000
Q2 2021 Mar 30, 2023	BUY	$107.45 - $135.95 $174,928 - $221,326	1,628 Added 36.19%	6,127 $698,000
Q2 2021 Aug 16, 2021	BUY	$107.45 - $135.95 $657,916 - $832,421	6,123 Added 153075.0%	6,127 $698,000
Q1 2021 Jun 26, 2023	BUY	$95.46 - $133.08 $429,474 - $598,726	4,499 New	4,499 $541 Million
Q1 2021 Mar 30, 2023	SELL	$95.46 - $133.08 $26,346 - $36,730	-276 Reduced 5.78%	4,499 $540,000
Q1 2021 May 14, 2021	SELL	$95.46 - $133.08 $455,439 - $634,924	-4,771 Reduced 99.92%	4 $541,000
Q4 2020 Jun 22, 2023	BUY	$75.23 - $109.23 $359,223 - $521,573	4,775 New	4,775 $485,000
Q3 2020 Jun 26, 2023	BUY	$71.31 - $109.74 $340,505 - $524,008	4,775 New	4,775 $369,000
Q2 2020 Jun 26, 2023	BUY	$62.14 - $117.21 $296,718 - $559,677	4,775 New	4,775 $532,000
Q2 2020 Mar 30, 2023	BUY	$62.14 - $117.21 $93,023 - $175,463	1,497 Added 45.67%	4,775 $532,000
Q2 2020 Aug 14, 2020	BUY	$62.14 - $117.21 $93,023 - $175,463	1,497 Added 45.67%	4,775 $532,000
Q1 2020 Jul 12, 2023	BUY	$60.41 - $115.92 $198,023 - $379,985	3,278 New	3,278 $236,000
Q1 2020 Mar 30, 2023	BUY	$60.41 - $115.92 $99,797 - $191,499	1,652 Added 101.6%	3,278 $236,000
Q1 2020 May 15, 2020	BUY	$60.41 - $115.92 $99,797 - $191,499	1,652 Added 101.6%	3,278 $236,000
Q4 2019 Jul 12, 2023	BUY	$11.44 - $123.99 $18,601 - $201,607	1,626 New	1,626 $122,000
Q4 2019 Mar 30, 2023	SELL	$11.44 - $123.99 $2,757 - $29,881	-241 Reduced 12.91%	1,626 $122,000
Q4 2019 Feb 14, 2020	BUY	$11.44 - $123.99 $18,601 - $201,607	1,626 New	1,626 $123,000

Others Institutions Holding KRTX

# of Institutions

Shares Held

332K

Call Options Held

Put Options Held

View Full List

About Karuna Therapeutics, Inc.

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

More about KRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account